Antigen receptor signalling: a distinctive role for the p110δ isoform of PI3K

Trends in Immunology

Volumn 28, Issue 2, 2007, Pages 80-87

  Okkenhaug, Klaus ^a   Ali, Khaled ^b,c   Vanhaesebroeck, Bart ^b,c  

^a BABRAHAM INSTITUTE   (United Kingdom)

^b LUDWIG INSTITUTE FOR CANCER RESEARCH   (United Kingdom)

^c UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM; CYTOKINE; LYMPHOCYTE ANTIGEN RECEPTOR; PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE; PROTEIN KINASE C; PROTEIN P110; RAS PROTEIN; TRIPHOSPHOINOSITIDE;

ANTIGEN RECOGNITION; B LYMPHOCYTE; CALCIUM TRANSPORT; CYTOKINE PRODUCTION; EFFECTOR CELL; ENZYME INACTIVATION; EXOCYTOSIS; GENE EXPRESSION; GLUCOSE METABOLISM; GLUCOSE TRANSPORT; MAST CELL; NONHUMAN; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; RECEPTOR UPREGULATION; REVIEW; SIGNAL TRANSDUCTION; T LYMPHOCYTE;

1-PHOSPHATIDYLINOSITOL 3-KINASE; ANIMALS; CELL DIFFERENTIATION; HUMANS; LYMPHOCYTES; PROTEIN SUBUNITS; RECEPTORS, ANTIGEN; SIGNAL TRANSDUCTION;

EID: 33846621025     PISSN: 14714906     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.it.2006.12.007     Document Type: Review

References (93)

1. Vanhaesebroeck B., et al. Synthesis and function of 3-phosphorylated inositol lipids. Annu. Rev. Biochem. 70 (2001) 535-602
2. Suire S., et al. Gβγs and the Ras binding domain of p110γ are both important regulators of PI3Kγ signalling in neutrophils. Nat. Cell Biol. 8 (2006) 1303-1309
3. Ward S.G. T lymphocytes on the move: chemokines, PI 3-kinase and beyond. Trends Immunol. 27 (2006) 80-87
4. Sasaki T., et al. Function of PI3Kγ in thymocyte development, T cell activation, and neutrophil migration. Science 287 (2000) 1040-1046
5. Laffargue M., et al. Phosphoinositide 3-kinase γ is an essential amplifier of mast cell function. Immunity 16 (2002) 441-451
6. Clayton E., et al. A crucial role for the p110δ subunit of phosphatidylinositol 3-kinase in B cell development and activation. J. Exp. Med. 196 (2002) 753-763
7. Jou S.T., et al. Essential, nonredundant role for the phosphoinositide 3-kinase p110δ in signaling by the B-cell receptor complex. Mol. Cell. Biol. 22 (2002) 8580-8591
8. Okkenhaug K., et al. Impaired B and T cell antigen receptor signaling in p110δ PI 3-kinase mutant mice. Science 297 (2002) 1031-1034
9. Bilancio A., et al. Key role of the p110δ isoform of PI3K in B-cell antigen and IL-4 receptor signaling: comparative analysis of genetic and pharmacologic interference with p110δ function in B cells. Blood 107 (2006) 642-650
10. Ali K., et al. Essential role for the p110δ phosphoinositide 3-kinase in the allergic response. Nature 431 (2004) 1007-1011
11. Lee K.S., et al. Inhibition of phosphoinositide 3-kinase δ attenuates allergic airway inflammation and hyperresponsiveness in murine asthma model. FASEB J. 20 (2006) 455-465
12. Leverrier Y., et al. Class I phosphoinositide 3-kinase p110β is required for apoptotic cell and Fcγ receptor-mediated phagocytosis by macrophages. J. Biol. Chem. 278 (2003) 38437-38442
13. Vanhaesebroeck B., et al. Signalling by PI3K isoforms: insights from gene-targeted mice. Trends Biochem. Sci. 30 (2005) 194-204
14. Okkenhaug K., et al. The p110δ isoform of phosphoinositide 3-kinase controls clonal expansion and differentiation of Th cells. J. Immunol. 177 (2006) 5122-5128
15. Gallo E.M., et al. Lymphocyte calcium signaling from membrane to nucleus. Nat. Immunol. 7 (2006) 25-32
16. Samelson L.E. Signal transduction mediated by the T cell antigen receptor: the role of adapter proteins. Annu. Rev. Immunol. 20 (2002) 371-394
17. Niiro H., and Clark E.A. Decision making in the immune system: regulation of B-cell fate by antigen-receptor signals. Nat. Rev. Immunol. 2 (2002) 945-956
18. Koretzky G.A., et al. SLP76 and SLP65: complex regulation of signalling in lymphocytes and beyond. Nat. Rev. Immunol. 6 (2006) 67-78
19. Gilfillan A.M., and Tkaczyk C. Integrated signalling pathways for mast-cell activation. Nat. Rev. Immunol. 6 (2006) 218-230
20. Thome M. CARMA1, BCL-10 and MALT1 in lymphocyte development and activation. Nat. Rev. Immunol. 4 (2004) 348-359
21. Diehn M., et al. Genomic expression programs and the integration of the CD28 costimulatory signal in T cell activation. Proc. Natl. Acad. Sci. U. S. A. 99 (2002) 11796-11801
22. Riley J.L., et al. Modulation of TCR-induced transcriptional profiles by ligation of CD28, ICOS, and CTLA-4 receptors. Proc. Natl. Acad. Sci. U. S. A. 99 (2002) 11790-11795
23. Welch H.C., et al. Phosphoinositide 3-kinase-dependent activation of Rac. FEBS Lett. 546 (2003) 93-97
24. Vanhaesebroeck B., and Alessi D.R. The PI3K-PDK1 connection: more than just a road to PKB. Biochem. J. 346 (2000) 561-576
25. Milburn C.C., et al. Binding of phosphatidylinositol 3,4,5-trisphosphate to the pleckstrin homology domain of protein kinase B induces a conformational change. Biochem. J. 375 (2003) 531-538
26. Lemmon M.A., and Ferguson K.M. Signal-dependent membrane targeting by pleckstrin homology (PH) domains. Biochem. J. 350 (2000) 1-18
27. Krystal G. Lipid phosphatases in the immune system. Semin. Immunol. 12 (2000) 397-403
28. Sasaki T., et al. Phosphoinositide 3-kinases in immunity: lessons from knockout mice. J. Biochem. (Tokyo) 131 (2002) 495-501
29. Krahn A.K., et al. Two distinct waves of membrane-proximal B cell antigen receptor signaling differentially regulated by Src homology 2-containing inositol polyphosphate 5-phosphatase. J. Immunol. 172 (2004) 331-339
30. Okkenhaug K., and Vanhaesebroeck B. PI3K in lymphocyte development, differentiation and activation. Nat. Rev. Immunol. 3 (2003) 317-330
31. Deane J.A., and Fruman D.A. Phosphoinositide 3-kinase: diverse roles in immune cell activation. Annu. Rev. Immunol. 22 (2004) 563-598
32. Koyasu S. The role of PI3K in immune cells. Nat. Immunol. 4 (2003) 313-319
33. Harriague J., and Bismuth G. Imaging antigen-induced PI3K activation in T cells. Nat. Immunol. 3 (2002) 1090-1096
34. Costello P.S., et al. Sustained and dynamic inositol lipid metabolism inside and outside the immunological synapse. Nat. Immunol. 3 (2002) 1082-1089
35. Huppa J.B., et al. Continuous T cell receptor signaling required for synapse maintenance and full effector potential. Nat. Immunol. 4 (2003) 749-755
36. Astoul E., et al. The dynamics of protein kinase B regulation during B cell antigen receptor engagement. J. Cell Biol. 145 (1999) 1511-1520
37. Kane L.P., et al. A proline-rich motif in the C terminus of Akt contributes to its localization in the immunological synapse. J. Immunol. 172 (2004) 5441-5449
38. Fabre S., et al. Stable activation of phosphatidylinositol 3-kinase in the T cell immunological synapse stimulates Akt signaling to FoxO1 nuclear exclusion and cell growth control. J. Immunol. 174 (2005) 4161-4171
39. Kolsch U., et al. Normal T-cell development and immune functions in TRIM-deficient mice. Mol. Cell. Biol. 26 (2006) 3639-3648
40. Yamazaki T., et al. Essential immunoregulatory role for BCAP in B cell development and function. J. Exp. Med. 195 (2002) 535-545
41. Moon K.D., et al. Molecular basis for a direct interaction between the Syk protein-tyrosine kinase and phosphoinositide 3-kinase. J. Biol. Chem. 280 (2005) 1543-1551
42. Shim E.K., et al. Association of the Src homology 2 domain-containing leukocyte phosphoprotein of 76 kD (SLP-76) with the p85 subunit of phosphoinositide 3-kinase. FEBS Lett. 575 (2004) 35-40
43. Rodriguez-Viciana P., et al. Signaling specificity by Ras family GTPases is determined by the full spectrum of effectors they regulate. Mol. Cell. Biol. 24 (2004) 4943-4954
44. Donahue A.C., and Fruman D.A. PI3K signaling controls cell fate at many points in B lymphocyte development and activation. Semin. Cell Dev. Biol. 15 (2004) 183-197
45. Yusuf I., et al. Optimal B-cell proliferation requires phosphoinositide 3-kinase-dependent inactivation of FOXO transcription factors. Blood 104 (2004) 784-787
46. Glassford J., et al. Phosphatidylinositol 3-kinase is required for the transcriptional activation of cyclin D2 in BCR activated primary mouse B lymphocytes. Eur. J. Immunol. 35 (2005) 2748-2761
47. Donahue A.C., and Fruman D.A. Proliferation and survival of activated B cells requires sustained antigen receptor engagement and phosphoinositide 3-kinase activation. J. Immunol. 170 (2003) 5851-5860
48. Vigorito E., et al. Synergistic activation of PKD by the B cell antigen receptor and CD19 requires PI3K, Vav1 and PLCγ. Cell. Signal. 18 (2006) 1455-1460
49. Doughty C.A., et al. Antigen receptor-mediated changes in glucose metabolism in B lymphocytes: role of phosphatidylinositol 3-kinase signaling in the glycolytic control of growth. Blood 107 (2006) 4458-4465
50. Piatelli M.J., et al. Phosphatidylinositol 3-kinase-dependent mitogen-activated protein/extracellular signal-regulated kinase kinase 1/2 and NF-κB signaling pathways are required for B cell antigen receptor-mediated cyclin D2 induction in mature B cells. J. Immunol. 172 (2004) 2753-2762
51. Hebeis B.J., et al. The p110δ subunit of phosphoinositide 3-kinase is required for the lipopolysaccharide response of mouse B cells. Biochem. Soc. Trans. 32 (2004) 789-791
52. Fruman D.A., et al. Xid-like phenotypes: a B cell signalosome takes shape. Immunity 13 (2000) 1-3
53. Suzuki H., et al. PI3K and Btk differentially regulate B cell antigen receptor-mediated signal transduction. Nat. Immunol. 4 (2003) 280-286
54. Dai X., et al. Distinct roles of phosphoinositide-3 kinase and phospholipase Cγ2 in B-cell receptor-mediated signal transduction. Mol. Cell. Biol. 26 (2006) 88-99
55. Del Nagro C.J., et al. CD19 function in central and peripheral B-cell development. Immunol. Res. 31 (2005) 119-131
56. Inabe K., et al. Vav3 modulates B cell receptor responses by regulating phosphoinositide 3-kinase activation. J. Exp. Med. 195 (2002) 189-200
57. Vigorito E., et al. Vav-dependent and vav-independent phosphatidylinositol 3-kinase activation in murine B cells determined by the nature of the stimulus. J. Immunol. 173 (2004) 3209-3214
58. Wang Y., et al. The physiologic role of CD19 cytoplasmic tyrosines. Immunity 17 (2002) 501-514
59. Anzelon A.N., et al. Pten inactivation alters peripheral B lymphocyte fate and reconstitutes CD19 function. Nat. Immunol. 4 (2003) 287-294
60. Brauweiler A.M., and Cambier J.C. FcγRIIB activation leads to inhibition of signalling by independently ligated receptors. Biochem. Soc. Trans. 31 (2003) 281-285
61. Suzuki A., et al. Critical roles of Pten in B cell homeostasis and immunoglobulin class switch recombination. J. Exp. Med. 197 (2003) 657-667
62. Omori S.A., et al. Regulation of class-switch recombination and plasma cell differentiation by phosphatidylinositol 3-kinase signaling. Immunity 25 (2006) 545-557
63. Suzuki A., et al. T cell-specific loss of Pten leads to defects in central and peripheral tolerance. Immunity 14 (2001) 523-534
64. Hagenbeek T.J., et al. The loss of PTEN allows TCR αβ lineage thymocytes to bypass IL-7 and pre-TCR-mediated signaling. J. Exp. Med. 200 (2004) 883-894
65. Williams J.A., et al. Regulated costimulation in the thymus is critical for T cell development: dysregulated CD28 costimulation can bypass the pre-TCR checkpoint. J. Immunol. 175 (2005) 4199-4207
66. Webb L.M., et al. Cutting edge: T cell development requires the combined activities of the p110γ and p110δ catalytic isoforms of phosphatidylinositol 3-kinase. J. Immunol. 175 (2005) 2783-2787
67. Swat W., et al. Essential role of PI3Kδ and PI3Kγ in thymocyte survival. Blood 107 (2006) 2415-2422
68. + regulatory T cells. J. Immunol. 177 (2006) 6598-6602
69. Rudd C.E., and Schneider H. Unifying concepts in CD28, ICOS and CTLA4 co-receptor signalling. Nat. Rev. Immunol. 3 (2003) 544-556
70. Vanhaesebroeck B., et al. Autophosphorylation of p110δ phosphoinositide 3-kinase: a new paradigm for the regulation of lipid kinases in vitro and in vivo. EMBO J. 18 (1999) 1292-1302
71. Charvet C., et al. Vav1 promotes T cell cycle progression by linking TCR/CD28 costimulation to FOXO1 and p27kip1 expression. J. Immunol. 177 (2006) 5024-5031
72. Frauwirth K.A., et al. The CD28 signaling pathway regulates glucose metabolism. Immunity 16 (2002) 769-777
73. Wu L.X., et al. CD28 regulates the translation of Bcl-xL via the phosphatidylinositol 3-kinase/mammalian target of rapamycin pathway. J. Immunol. 174 (2005) 180-194
74. Fox C.J., et al. The Pim kinases control rapamycin-resistant T cell survival and activation. J. Exp. Med. 201 (2005) 259-266
75. Nashed, B.F. et al. Role of the phosphoinositide 3-kinase p110δ in the generation of type 2 cytokine responses and allergic airway inflammation. Eur. J. Immunol. (in press)
76. Lin L., et al. Regulation of NF-κB, Th activation, and autoinflammation by the forkhead transcription factor Foxo3a. Immunity 21 (2004) 203-213
77. + regulatory T cells for immunologic self-tolerance and negative control of immune responses. Annu. Rev. Immunol. 22 (2004) 531-562
78. Coombes J.L., et al. Regulatory T cells and intestinal homeostasis. Immunol. Rev. 204 (2005) 184-194
79. Oak J.S., et al. Sjogren's syndrome-like disease in mice with T cells lacking class 1A phosphoinositide-3-kinase. Proc. Natl. Acad. Sci. U. S. A. 103 (2006) 16882-16887
80. Wilson B.S., et al. FcεRI signaling observed from the inside of the mast cell membrane. Mol. Immunol. 38 (2002) 1259-1268
81. 1-dependent pathway of FcεRI-mediated mast cell activation is regulated independently of phosphatidylinositol 3-kinase. J. Biol. Chem. 278 (2003) 48474-48484
82. Furumoto Y., et al. Cutting edge: lentiviral short hairpin RNA silencing of PTEN in human mast cells reveals constitutive signals that promote cytokine secretion and cell survival. J. Immunol. 176 (2006) 5167-5171
83. Rivera J., and Gilfillan A.M. Molecular regulation of mast cell activation. J. Allergy Clin. Immunol. 117 (2006) 1214-1225
84. Kitaura J., et al. Akt-dependent cytokine production in mast cells. J. Exp. Med. 192 (2000) 729-740
85. Lee J.S., et al. Phosphatidylinositol (3,4,5)-trisphosphate specifically interacts with the phox homology domain of phospholipase D1 and stimulates its activity. J. Cell Sci. 118 (2005) 4405-4413
86. Peng Z., and Beaven M.A. An essential role for phospholipase D in the activation of protein kinase C and degranulation in mast cells. J. Immunol. 174 (2005) 5201-5208
87. Okada T., et al. BCAP: the tyrosine kinase substrate that connects B cell receptor to phosphoinositide 3-kinase activation. Immunity 13 (2000) 817-827
88. Itoh S., et al. Adapter molecule Grb2-associated binder 1 is specifically expressed in marginal zone B cells and negatively regulates thymus-independent antigen-2 responses. J. Immunol. 168 (2002) 5110-5116
89. Wang Y., et al. Single and combined deletions of the NTAL/LAB and LAT adaptors minimally affect B-cell development and function. Mol. Cell. Biol. 25 (2005) 4455-4465
90. Wood J.E., et al. TcR and TcR-CD28 engagement of protein kinase B (PKB/AKT) and glycogen synthase kinase-3 (GSK-3) operates independently of guanine nucleotide exchange factor VAV-1. J. Biol. Chem. 281 (2006) 32385-32394
91. Reynolds L.F., et al. Vav1 transduces T cell receptor signals to the activation of phospholipase C-γ1 via phosphoinositide 3-kinase-dependent and -independent pathways. J. Exp. Med. 195 (2002) 1103-1114
92. Barber D.F., et al. Class IB-phosphatidylinositol 3-kinase (PI3K) deficiency ameliorates IA-PI3K-induced systemic lupus but not T cell invasion. J. Immunol. 176 (2006) 589-593
93. Deane J.A. et al. T cell function is partially maintained in the absence of class IA phosphoinositide 3-kinase signaling Blood (in press)